Large gap with delayed quotes
|
Last quote
03/02/2026
-
16:49:43
|
Bid
03/02/2026 -
16:49:56
|
Bid Volume |
Ask
03/02/2026 -
16:49:56
|
Ask Volume |
|---|---|---|---|---|
|
308.30
-11.70
(
-3.66% )
|
308.00
|
40 |
308.46
|
40 |
Analysis date: 27.02.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 27.01.2026.
Interest
Very weak
Very weak
One star since 30.01.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 30.01.2026 at a price of 345.74.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 27.01.2026.
4wk Rel Perf
0.53%
0.53%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
High
High
The stock has been on the high-sensitivity level since 08.07.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.29%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.97%.
Mkt Cap in $bn
70.63
70.63
With a market capitalization >$8bn, ELEVANCE HEALTH is considered a large-cap stock.
G/PE Ratio
0.69
0.69
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
11.75
11.75
The estimated PE is for the year 2027.
LT Growth
5.90%
5.90%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
21
21
Over the last seven weeks, an average of 21 analysts provided earnings per share estimates.
Dividend Yield
2.24%
2.24%
The twelve month estimated dividend yield represents 26.36% of earnings forecasts.
Beta
0
0
For 1% of index variation, the stock varies on average by 0.00%.
Correlation
0
0
Stock movements are totally independent of index variations.
Value at Risk
78.32
78.32
The value at risk is estimated at USD 78.32. The risk is therefore 24.48%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004